Nam, Sung Min Choi, Jong Hee Choi, Sun-Hye Cho, Hee-Jung Cho, Yeon-Jin Rhim, Hyewhon Kim, Hyoung-Chun Cho, Ik-Hyun Kim, Do-Geun Nah, Seung-Yeol 2024-01-19T15:00:50Z 2024-01-19T15:00:50Z 2021-09-04 2021-05 1226-8453 https://pubs.kist.re.kr/handle/201004/117098 Background: We recently showed that gintonin, an active ginseng ingredient, exhibits antibrain neurodegenerative disease effects including multiple target mechanisms such as antioxidative stress and antiinflammation via the lysophosphatidic acid (LPA) receptors. Amyotrophic lateral sclerosis (ALS) is a spinal disease characterized by neurodegenerative changes in motor neurons with subsequent skeletal muscle paralysis and death. However, pathophysiological mechanisms of ALS are still elusive, and therapeutic drugs have not yet been developed. We investigate the putative alleviating effects of gintonin in ALS. Methods: The G93A-SOD1 transgenic mouse ALS model was used. Gintonin (50 or 100 mg/kg/day, p.o.) administration started from week seven. We performed histological analyses, immunoblot assays, and behavioral tests. Results: Gintonin extended mouse survival and relieved motor dysfunctions. Histological analyses of spinal cords revealed that gintonin increased the survival of motor neurons, expression of brain-derived neurotrophic factors, choline acetyltransferase, NeuN, and Nissl bodies compared with the vehicle control. Gintonin attenuated elevated spinal NAD(P) quinone oxidoreductase 1 expression and decreased oxidative stress-related ferritin, ionized calcium-binding adapter molecule 1-immunoreactive microglia, S100b-immunoreactive astrocyte, and Olig2-immunoreactive oligodendrocytes compared with the control vehicle. Interestingly, we found that the spinal LPA1 receptor level was decreased, whereas gintonin treatment restored decreased LPA1 receptor expression levels in the G93A-SOD1 transgenic mouse, thereby attenuating neurological symptoms and histological deficits. Conclusion: Gintonin-mediated symptomatic improvements of ALS might be associated with the attenuations of neuronal loss and oxidative stress via the spinal LPA1 receptor regulations. The present results suggest that the spinal LPA1 receptor is engaged in ALS, and gintonin may be useful for relieving ALS symptoms. (C) 2020 The Korean Society of Ginseng. Publishing services by Elsevier B.V. English 고려인삼학회 Ginseng gintonin alleviates neurological symptoms in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis through lysophosphatidic acid 1 receptor Article 10.1016/j.jgr.2020.04.002 1 Journal of Ginseng Research, v.45, no.3, pp.390 - 400 Journal of Ginseng Research 45 3 390 400 Y scie scopus kci ART002724202 000652190700004 2-s2.0-85085355928 Plant Sciences Chemistry, Medicinal Integrative & Complementary Medicine Plant Sciences Pharmacology & Pharmacy Integrative & Complementary Medicine Article NERVOUS-SYSTEM NADPH OXIDASE ACTIVATION MICE ALS NEUROGENESIS DEGENERATION PHARMACOLOGY INVOLVEMENT MUTATIONS ALS ginseng gintonin motor activity spinal cord